Abeona Therapeutics, Inc. (ABEO)
6.045
+0.04
(+0.58%)
USD |
NASDAQ |
Aug 27, 16:00
6.045
0.00 (0.00%)
After-Hours: 20:00
Abeona Therapeutics EPS Diluted (TTM) : -1.122 for June 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.122 |
| March 31, 2026 | 0.9372 |
| December 31, 2025 | 0.9972 |
| September 30, 2025 | 1.165 |
| June 30, 2025 | 0.631 |
| March 31, 2025 | -1.337 |
| December 31, 2024 | -2.252 |
| September 30, 2024 | -2.697 |
| June 30, 2024 | -2.545 |
| March 31, 2024 | -3.207 |
| December 31, 2023 | -2.590 |
| September 30, 2023 | -2.004 |
| June 30, 2023 | -2.529 |
| March 31, 2023 | -2.961 |
| December 31, 2022 | -97.52 |
| September 30, 2022 | -108.60 |
| June 30, 2022 | -109.40 |
| March 31, 2022 | -111.98 |
| December 31, 2021 | -21.13 |
| September 30, 2021 | -14.24 |
| June 30, 2021 | -14.37 |
| March 31, 2021 | -13.93 |
| December 31, 2020 | -22.68 |
| September 30, 2020 | -25.92 |
| June 30, 2020 | -32.73 |
| Date | Value |
|---|---|
| March 31, 2020 | -41.45 |
| December 31, 2019 | -38.13 |
| September 30, 2019 | -39.21 |
| June 30, 2019 | -36.95 |
| March 31, 2019 | -30.33 |
| September 30, 2018 | -25.40 |
| June 30, 2018 | -20.06 |
| March 31, 2018 | -18.84 |
| December 31, 2017 | -16.50 |
| September 30, 2017 | -16.50 |
| June 30, 2017 | -15.25 |
| March 31, 2017 | -15.00 |
| December 31, 2016 | -16.00 |
| September 30, 2016 | -13.00 |
| June 30, 2016 | -15.75 |
| March 31, 2016 | -14.75 |
| December 31, 2015 | -13.00 |
| September 30, 2015 | -27.06 |
| June 30, 2015 | -126.06 |
| March 31, 2015 | -759.56 |
| December 31, 2014 | -832.06 |
| September 30, 2014 | -903.75 |
| June 30, 2014 | -850.00 |
| March 31, 2014 | -175.00 |
| December 31, 2013 | 62.50 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Corcept Therapeutics, Inc. | 0.4187 |
| Forum Markets, Inc. | -33.18 |
| ACADIA Pharmaceuticals, Inc. | 2.220 |
| Alnylam Pharmaceuticals, Inc. | 5.923 |
| Anika Therapeutics, Inc. | -0.2741 |